BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, March 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 29, 2017
View Archived Issues
mGlu4 receptor found as a target for treating maladaptive impulsivity
Read More
PhoenixMD reports favorable preclinical data on RSK inhibitor for TNBC
Read More
FDA advisory committee recommends approval of Pfizer's epoetin alfa biosimilar
Read More
Orexin OX2 receptor agonist as promising new therapeutic approach for narcolepsy-cataplexy symptoms
Read More
Hovione begins phase I study of HY-02
Read More
Lundbeck patents P2X7 receptor antagonists
Read More
Hubei Biological Medicine Industrial Technology Institute and collaborator divulge ALK inhibitors
Read More
Jiangsu Hansoh Pharmaceutical Group identifies compounds against HCV
Read More
Merck KGaA discovers PARP-1 and TANK1/2 inhibitors
Read More
Roche presents equilibrative nucleoside transporter 1 inhibitors
Read More
Ciprofloxacin DPI benefit not significant in phase III bronchiectasis trial
Read More
FDA grants priority review to axicabtagene ciloleucel BLA
Read More
FDA grants approval for expanded use of Zykadia in first-line ALK-positive metastatic NSCLC
Read More
FDA issues complete response letter for SUN-101/eFlow
Read More
Valerion Therapeutics begins recruitment in phase I/II trial of VAL-1221
Read More
ENaC inhibitor AZD-5634 shows reduced potential for side effects in first-in-human study
Read More
Targeting KLF5 for the treatment of colorectal cancer
Read More
FDA grants orphan designation to liposome irinotecan injection for small cell lung cancer
Read More
Model recapitulates features of chronic human empyema
Read More
Galderma's resiquimod named U.S. orphan drug for cutaneous T-cell lymphoma
Read More
